Giora Sharf  -     CML  -     Chronic myeloid leukemia


Giora Sharf
​
‘I feel that my personal story reflects on the revolution that CML has gone through in the last 20 years. I was diagnosed with CML in March 2000. Through the Internet, I found out about the opening of the IRIS clinical trial and joined it in July 2000. I was randomized to interferon-alpha and took it for seven months. I was then switched to imatinib, which I took daily for 13 years and reached MR5. In June 2014, I stopped treatment and am monitored by PCR tests, which show that I am still in high molecular response. Let’s hope we can all reach a cure!’ (Giora Sharf)
Giora Sharf decided to use his experience to help other CML patients by founding the Israeli CML Patients’ Organization in April 2001. Starting with seven local patients in a small hospital basement, his organization has since then grown to support more than 500 patients from all around the country. In 2014, Giora founded a new Israelian Blood Cancer Patients’ Organization named ‘Flute of Light’ for patients with leukemia, lymphoma and other blood cancers in Israel.
He is one of the co-founders of the Leukemia Patient Advocates Foundation that hosts the CML Advocates Network, the Acute Leukemia Advocates Network (ALAN), the CLL Advocates Network, the MPN Advocates Network and the CML Horizons meeting. Giora Sharf is also involved in the Steering Committees of the CML Advocates Network and the MPN Advocates Network.

Extract of iCMLf - The 2022 iCMLf Prize is awarded to Giora Sharf and Jan Geissler

                                               See  Giora Sharf on Facebook
                                    See  Giora Sharf on Twitter
​